Fintepla 2.2 mg/mL oral solution Images

Generic Name: fenfluramine

This medication has been identified as Fintepla 2.2 mg/mL oral solution. It is supplied by Zogenix, Inc.

Fintepla is used in the treatment of Dravet Syndrome; Lennox-Gastaut Syndrome and belongs to the drug classes CNS stimulants, miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Fintepla 2.2 mg/mL oral solution is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images of medication

Fintepla

Generic Name

fenfluramine

Strength

2.2 mg/mL oral solution

Availability

Prescription only

Drug Class

CNS stimulants, Miscellaneous anticonvulsants

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

4 - Some potential for abuse

Labeler / Supplier

Zogenix, Inc.

National Drug Code (NDC)

43376-0322

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer